Impact of Transarterial Chemoembolization or Hepatic Artery Infusion Chemotherapy on Liver Function after Hepatocellular Carcinoma Resection: An Observational Study

被引:3
|
作者
Yue, Rongbin [1 ]
Liu, Xiqiang [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 5, Div Hepatol, Zhuhai, Peoples R China
关键词
Hepatocellular carcinoma; Transarterial chemoembolization; Hepatic artery infusion chemotherapy; Liver function; Postoperation; POSTOPERATIVE TACE; TUMOR THROMBUS; FAILURE; 5-FLUOROURACIL; PROGNOSIS; MRI; HCC;
D O I
10.1159/000528750
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Liver surgery leads to a high degree of heterogeneity in the prognosis of hepatocellular carcinoma (HCC) patients. However, most previous studies focused on the postoperative therapeutic effects of other treatments, with relatively few studies on the impacts on liver function. This study investigated the impact of transarterial chemoembolization (TACE) and hepatic artery infusion chemotherapy (HAIC) on liver function after HCC resection from various angles. Methods: 138 HCC patients were enrolled, including 27 patients who received TACE and 80 patients who received HAIC. Besides routine treatment such as liver protection and antiviral therapy, 31 patients received no other treatment. The different groups were compared with various biological parameters with four types of scoring methods. Results: In the short term after TACE, the mean (+/- SD) alanine transaminase and aspartate transaminase values increased by 79.22 +/- 117.43 U/L and 66.33 +/- 94.54 U/L, respectively (p < 0.01). The mean (+/- SD) total bilirubin (TBIL) values increased by 4.02 +/- 6.08 mu mol/L (p < 0.01). The mean (+/- SD) albumin (ALB) values decreased by 3.54 +/- 2.93 g/L (p < 0.001). The mean (+/- SD) albumin bilirubin (ALBI) scores increased by 0.39 +/- 0.22 (p < 0.001). In the short term after HAIC, the mean (+/- SD) TBIL values increased by 2.11 +/- 5.57 mu mol/L (p < 0.01). The mean (+/- SD) ALB values decreased by 2.52 +/- 3.26 g/L (p < 0.001), and the mean (+/- SD) ALBI scores increased by 0.21 +/- 0.42 (p < 0.001). In both treatment groups, the long-term liver function was not significantly different from that before treatment and also from that of the untreated group (p > 0.05). Conclusion: TACE after HCC resection has a significant impact on short-term liver function, whereas HAIC has a relatively small impact, but neither has a major impact on long-term liver function.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 50 条
  • [31] Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma
    Shao-Liang Zhu
    Jian-Hong Zhong
    Yang Ke
    Liang Ma
    Xue-Mei You
    Le-Qun Li
    World Journal of Gastroenterology, 2015, (32) : 9630 - 9637
  • [32] Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection
    Chen, Xiaohong
    Zhang, Boheng
    Yin, Xin
    Ren, Zhenggang
    Qiu, Shuangjian
    Zhou, Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (05) : 773 - 781
  • [33] Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection
    Xiaohong Chen
    Boheng Zhang
    Xin Yin
    Zhenggang Ren
    Shuangjian Qiu
    Jian Zhou
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 773 - 781
  • [34] Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma
    Decaens, T
    Roudot-Thoraval, F
    Bresson-Hadni, S
    Meyer, C
    Gugenheim, J
    Durand, F
    Bernard, PH
    Boillot, O
    Boudjema, K
    Calmus, Y
    Hardwigsen, J
    Ducerf, C
    Pageaux, GP
    Dharancy, S
    Chazouilleres, O
    Dhumeaux, D
    Cherqui, D
    Duvoux, C
    LIVER TRANSPLANTATION, 2005, 11 (07) : 767 - 775
  • [35] Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study
    Chen, Junwei
    Lai, Lisha
    Lin, Qu
    Huang, Wensou
    Cai, Mingyue
    Zhu, Kangshun
    Huang, Mingsheng
    ONCOTARGET, 2017, 8 (01) : 408 - 417
  • [36] Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization
    Jang, Eun Sun
    Yoon, Jung-Hwan
    Chung, Jin Wook
    Cho, Eun Ju
    Yu, Su Jong
    Lee, Jeong-Hoon
    Kim, Yoon Jun
    Lee, Hyo-Suk
    Kim, Chung Yong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (04) : 635 - 643
  • [37] Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization
    Eun Sun Jang
    Jung-Hwan Yoon
    Jin Wook Chung
    Eun Ju Cho
    Su Jong Yu
    Jeong-Hoon Lee
    Yoon Jun Kim
    Hyo-Suk Lee
    Chung Yong Kim
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 635 - 643
  • [38] Comparison of radiation doses between hepatic artery infusion chemotherapy and transarterial chemoembolization for liver cancer附视频
    Hui Yuan
    Hailei Lu
    Jiahuan Zeng
    Yan Zhang
    Lujun Shen
    Journal of Interventional Medicine, 2021, (04) : 184 - 189
  • [39] Hepatic arterial infusion chemotherapy for hepatocellular carcinoma resistant to transarterial embolization
    Sun, Wei-Chih
    Tsai, Wei-Lun
    Yu, Hsien-Chung
    Lai, Kwok-Hung
    Hsu, Ping-I
    Lin, Kung-Hung
    Chen, Wen-Chi
    Chan, Hoi-Hung
    Cheng, Jin-Shiung
    Liang, Huei-Lung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 356 - 357